- Home
- OABI vs ESEA Comparison
OABI vs ESEA Comparison
Compare OABI & ESEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- ESEA
- Stock Information
- Founded
- OABI 2012
- ESEA 2005
- Country
- OABI United States
- ESEA Greece
- Employees
- OABI N/A
- ESEA N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- ESEA Marine Transportation
- Sector
- OABI Health Care
- ESEA Consumer Discretionary
- Exchange
- OABI Nasdaq
- ESEA Nasdaq
- Market Cap
- OABI 198.2M
- ESEA 208.2M
- IPO Year
- OABI N/A
- ESEA 2006
- Fundamental
- Price
- OABI $1.93
- ESEA $47.51
- Analyst Decision
- OABI Strong Buy
- ESEA Strong Buy
- Analyst Count
- OABI 3
- ESEA 1
- Target Price
- OABI $7.00
- ESEA $62.00
- AVG Volume (30 Days)
- OABI 912.8K
- ESEA 43.5K
- Earning Date
- OABI 08-07-2025
- ESEA 06-18-2025
- Dividend Yield
- OABI N/A
- ESEA 5.47%
- EPS Growth
- OABI N/A
- ESEA 21.86
- EPS
- OABI N/A
- ESEA 18.62
- Revenue
- OABI $26,744,000.00
- ESEA $222,525,034.00
- Revenue This Year
- OABI N/A
- ESEA $5.14
- Revenue Next Year
- OABI $45.65
- ESEA $3.76
- P/E Ratio
- OABI N/A
- ESEA $2.49
- Revenue Growth
- OABI 27.07
- ESEA 14.62
- 52 Week Low
- OABI $1.22
- ESEA $24.58
- 52 Week High
- OABI $4.96
- ESEA $50.82
- Technical
- Relative Strength Index (RSI)
- OABI 69.01
- ESEA 71.35
- Support Level
- OABI $1.55
- ESEA $43.60
- Resistance Level
- OABI $1.73
- ESEA $47.88
- Average True Range (ATR)
- OABI 0.10
- ESEA 1.97
- MACD
- OABI 0.03
- ESEA -0.13
- Stochastic Oscillator
- OABI 100.00
- ESEA 60.30
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.